Skip to main content
. 2024 Sep 17;151(2):109–126. doi: 10.1111/acps.13758

FIGURE 4.

FIGURE 4

Nonadherence/discontinuation in individuals on APs with moderate weight gain liability versus APs with lower weight gain liability (Paliperidone, risperidone and quetiapine grouping vs. others).